生物
胶质母细胞瘤
PI3K/AKT/mTOR通路
体外
癌症研究
蛋白激酶B
DNA损伤
多重耐药
NF-κB
DNA
癌变
信号转导
细胞生物学
遗传学
癌症
抗药性
作者
G. Xi,Emily Hayes,R Lewis,Shunsuke Ichi,Barbara Mania-Farnell,Kyu-Hwan Shim,Toshifumi Takao,Elise Allender,Chandra S K Mayanil,Takuro Tomita
出处
期刊:Oncogene
[Springer Nature]
日期:2016-10-01
卷期号:35 (42): 5576-5576
被引量:12
摘要
The authors wish to retract this paper owing to the use of misidentified cell lines in the study. According to the description on the ATCC official website and reanalysis of the STR for cell line authentication, two misidentified glioblastoma cell lines, U251MG and U373MG, were used in this work.
科研通智能强力驱动
Strongly Powered by AbleSci AI